AshiBio

AshiBio is a biotech company in Cambridge, United States, founded in 2022. It has raised $40.0M across 2 rounds, most recently a Seed in June 2024.

Innovative therapeutics targeting novel pathways

Employees
11–50
Founded
2022
Business Model
B2B
Total Funding
$40.0M
Last Round
SeedJun 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.

About

AshiBio develops novel therapies for patients with bone and connective tissue disorders, aiming to prevent symptoms or slow disease progression. Its clinical pipeline includes andecaliximab for disorders characterized by heterotopic ossification and vantictumab for autosomal dominant osteopetrosis type 2.

Summary

It lists 11–50 employees. It has raised $40.0M in total across 2 rounds, most recently a Seed round in Jun 2024. Investors include MPM BioImpact, Agent Capital and YK Bioventures.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundJun 2024

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

AshiBio on Indexed.vc
<a href="https://indexed.vc/companies/ashibio"><img src="https://indexed.vc/api/badge/company/ashibio" alt="AshiBio on Indexed.vc" width="260" height="76" /></a>